Intresseområden
- Real world evidence and quality of life in patients with multiple myeloma including non-interventional studies
- Medical relevant questions for the use of melphalan flufenamide in already pursued indications (e.g. specific subgroups, treatment sequence)
- Exploratory and hypothesis generating questions
- B-cell malignancies outside myeloma other than areas that are being explored by Oncopeptides
The following areas will likely not support novel and independent research:
- Repetition of already answered/planned research questions
- Studies falling within the scope of ongoing or planned studies or concepts
- Studies with registrational intent
- Head-to-head studies
- Other than registered dosing schemes or routes of administration
Specific patient populations/ Indication, including: Pediatric, High-Dose/Transplantation, CNS involvement (Multiple Myeloma)